Winthrop P. Rockefeller Cancer Institute


December 15, 2023

Intake Team Serves as Source of Comfort for Myeloma Center Patients

Chris Carmody

(Left to right) Christy Bunting, Amy Ford, Melissa Thomas, April Thomas.

For new patients of the UAMS Myeloma Center, the intake process provides their first impression of the support they’ll receive during a difficult period of their lives. “It’s important that we help them get established and make sure they’re comfortable coming here,” said Christy Bunting, an intake coordinator in the Myeloma Center. “We want them…


UAMS Myeloma Researcher Sees‘ Impressive’ Results in Clinical Trials of Bispecific Antibody Treatments

David Robinson

Carolina Schinke, M.D.

Many patients at the UAMS Myeloma Center have relapsed refractory myeloma, meaning they have nearly run out of effective treatment options. Fortunately, the center has talented clinical researchers like Carolina Schinke, M.D., with access to the latest medications, including promising study drugs. Schinke is leading a clinical trial at UAMS of a promising new bispecific…


December 14, 2023

UAMS Researcher Takes Aim at Drug-Resistant Myeloma

David Robinson

Fenghuang (Frank) Zhan, M.D., Ph.D.

  UAMS Myeloma Center researcher Fenghuang (Frank) Zhan, M.D., Ph.D., has spent his career in search of clues to help fight drug-resistant myeloma. His findings recently led him to establish a translational research project to beat drug-resistant myeloma for his 11-member myeloma research team, based at the UAMS Winthrop P. Rockefeller Cancer Institute. While the…


New Immune Therapies Provide Promising Advances in Myeloma Care

News Staff

Frits van Rhee, MD, Ph.D.

By Frits van Rhee, MD, Ph.D. Since the late 1990s, 16 drugs have been approved for the treatment of multiple myeloma, including proteasome inhibitors, such as bortezomib and carfilzomib, and the immunomodulatory class of agents comprising thalidomide, lenalidomide and pomalidomide. Immune therapy with the antibody daratumumab was first approved in 2015. These three classes of…


Expanding the Field: Clinical Trials Diversity Benefits Myeloma Research

Nathan Tidwell

Samer Al Hadidi, M.D.

Clinical trials have long been an established part of medical research. The University of Arkansas for Medical Sciences (UAMS) Myeloma Center and the Clinical Trials Office work together to create a more diverse pool of clinical trial participants in the continuing research of multiple myeloma. Samer Al Hadidi, M.D., is a driving force in this…


December 11, 2023

Radiation Oncologist Ciani Ellison, M.D., Joins UAMS Winthrop P. Rockefeller Cancer Institute

Marty Trieschmann

Dr. Ciani Ellison

Ciani Ellison, M.D., a radiation oncologist specializing in the treatment of pediatric cancers has joined the Radiation Oncology Center at the Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute. She is one of only two pediatric radiation oncologists in Arkansas, both at UAMS. Ellison also treats adult patients with gynecologic cancers, soft tissue…


November 20, 2023

UAMS Myeloma Center Hits Impressive Milestone, Sees 1000th Article Published

Nathan Tidwell

Frits van Rhee, M.D, Ph.D.

Researchers and physicians with the Myeloma Center at the University of Arkansas for Medical Sciences (UAMS) recently published their 1,000th article, an impressive milestone that demonstrates the center’s high level of scholarship. “This is a remarkable achievement by our amazing Myeloma Center physicians and researchers,” said Frits van Rhee, M.D., Ph.D., clinical director of the…


November 7, 2023

Colorectal Surgeon S. Thomas Kang, M.D., Joins UAMS

Marty Trieschmann

UAMS Colorectal Surgeon Thomas Kang, M.D.

Thomas Kang, M.D., a fellowship-trained, board-certified surgeon, joined the University of Arkansas for Medical Sciences (UAMS) as an assistant professor in the UAMS College of Medicine’s Division of Colorectal Surgery. Kang treats patients with colon, rectal and anal cancers. He offers colon cancer surveillance with colonoscopies and performs minimally invasive laparoscopic and robotic assisted surgery….


October 25, 2023

26th Gala for Life Makes a Million Dollar Impact on Cancer Care in Arkansas

Marty Trieschmann

Chris and Kim Fowler

The 600 guests attending the 2023 Gala for Life benefitting the UAMS Winthrop P. Rockefeller Cancer Institute were transported to a tropical paradise complete with orchids and palm trees. The 26th Annual Gala for Life, “Sunset Under the Palms: A Key West Soiree,” was held Sept. 22 at Little Rock’s Statehouse Convention Center. The theme…


October 23, 2023

Five UAMS Researchers Awarded Grants for Breast Cancer Research

Marty Trieschmann

UAMS professor Ping-Ching Hsu, Ph.D.,

For the 26th year during Breast Cancer Awareness Month, the Arkansas Breast Cancer Research Program (ABCRP) has awarded funding to kick-start promising breast cancer research projects. Since the passage of the Arkansas Breast Cancer Act in 1997 that created the ABCRP, the Arkansas State Legislature has set aside funds that UAMS invests in novel research…



Previous page Next page